CSTL — Castle Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual balance sheet for Castle Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	410	330	259	243	293
Net Total Accounts Receivable
Net Total Receivables	12.8	17.3	23.5	38.3	51.2
Total Inventory
Prepaid Expenses
Total Current Assets	430	354	292	296	360
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.1	16.9	26.5	37.7	62.7
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	439	463	447	453	531
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	20.9	24.9	36.1	47.7	49.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	23.6	50.8	48.2	62.1	75.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	416	412	399	391	456
Total Liabilities & Shareholders' Equity	439	463	447	453	531
Total Common Shares Outstanding